Loading
InVirtuoLabs
InVirtuoLabs, a Lugano biotech startup, sells the modular InVirtuo Platform. It includes InVirtuoMOL for molecular machine learning, InVirtuoGEN for generative chemistry and InVirtuoSIM for physics-based simulation. Its customers are pharma and biotech firms, and it makes money from platform licensing, consulting and R&D collaborations. It also runs its own pipeline aimed at metabolic disease. It closed a €2.85M seed round in February 2025 after winning the Boldbrain Startup Challenge in December 2024. It launched the platform in July 2025 and later signed a strategic collaboration with Helsinn Healthcare.
Funding
Every round, secondary, debt facility or acquisition involving InVirtuoLabs that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—